Introduction
Brand name: Uropod 100 mg
Manufacturer: Astemax Biotech Pvt. Ltd. / Astelab United group
Product form: Cefpodoxime proxetil 100 mg oral suspension (orange flavour)
Uropod 100 mg is a third‑generation oral cephalosporin suspension containing cefpodoxime proxetil equivalent to 100 mg cefpodoxime per 5 ml (once constituted), with an orange‑flavoured base for better palatability in children. It is indicated for the treatment of susceptible bacterial infections in both adults and paediatric patients, including:
Respiratory tract infections (tonsillitis, pharyngitis, bronchitis, community‑acquired pneumonia).
Urinary tract infections (uncomplicated cystitis and pyelonephritis).
Skin and soft‑tissue infections (cellulitis, impetigo, wound infections).
ENT infections (otitis media, sinusitis).
Key features
Extended‑spectrum β‑lactam antibiotic active against many Gram‑positive and Gram‑negative pathogens such as Streptococcus pneumoniae, Haemophilus influenzae, Moraxella catarrhalis, and selected enteric organisms.
Oral suspension with orange flavour facilitates accurate weight‑based dosing and improves compliance in children.
Uropod 100 mg can be positioned as a WHO‑GMP‑oriented, paediatric‑friendly, high‑strength broad‑spectrum oral suspension for community‑acquired infections managed by general‑practitioners and paediatricians.
